Pharmacy Practice
Affordable Medicines
Biosimilars
Compliance
Compounding
Drug Approvals
Geriatrics
Hospital/Health System
In-Pharmacy Vaccines
Law
Medication Management
News & Trends
OTC
Pharmacist Resources
Specialty Pharmacy
Technology
Disease State
Allergy
Autoimmune
Breast Cancer
Cardiovascular
Cold & Flu
COVID-19
Dermatology
Diabetes
Gastroenterology
Hematology
HIV/AIDS
Infectious Disease
Infusion
Lung Cancer
Mental Health
mRNA Technology
Neurology
Oncology
Ophthalmology
Orthopedics
Pain Management
Pediatrics
Respiratory
Schizophrenia
Urology/Nephrology
Women’s Health
Health Awareness Month
Videos
Patient Teaching Aid
Publications
Featured Issue
Featured Supplements
Conference Coverage
Continuing Education
Subscribe
COVID-19 Resources
Biosimilars
September 14, 2023
Review Explores Patient Opinions About Biosimilars
September 14, 2023
Exploring Gaps, Challenges in Assessing Biosimilars’ Value
September 14, 2023
Study Compares Biosimilars With Their Reference Products
August 15, 2023
Survey Explores Patient Knowledge About Biosimilars
August 15, 2023
Trastuzumab Biosimilar Use in the Treatment of HER2+ BC
August 15, 2023
Spotlighting Safety of European Oncology Biosimilars
July 17, 2023
Implementing Biosimilars in the Medicare Oncology Care Model
July 17, 2023
Adopting Biosimilar Use in Clinical Practice
July 17, 2023
Factors Impacting Biosimilar Coverage Decisions
July 17, 2023
Factors Impacting Biosimilar Coverage Decisions
June 14, 2023
Study Explores Biosimilar Rituximab to Reference Product
June 14, 2023
Forecasting the Global Biosimilar Monoclonal Antibodies Market
June 14, 2023
New Developments in the Biosimilar of Bevacizumab
Load More
X
September 2023
In This Issue
Digital Magazine
Archives
Subscription
Related CE
$6.97 Per CE Exam or $59 for 12 Lessons
Spearheading the Implementation of a Biosimilar Program: The Pharmacist’s Role
×
Full Image